143 related articles for article (PubMed ID: 16802371)
1. Manipulation of isoprenoid biosynthesis as a possible therapeutic option in mevalonate kinase deficiency.
Schneiders MS; Houten SM; Turkenburg M; Wanders RJ; Waterham HR
Arthritis Rheum; 2006 Jul; 54(7):2306-13. PubMed ID: 16802371
[TBL] [Abstract][Full Text] [Related]
2. Lack of isoprenoid products raises ex vivo interleukin-1beta secretion in hyperimmunoglobulinemia D and periodic fever syndrome.
Frenkel J; Rijkers GT; Mandey SH; Buurman SW; Houten SM; Wanders RJ; Waterham HR; Kuis W
Arthritis Rheum; 2002 Oct; 46(10):2794-803. PubMed ID: 12384940
[TBL] [Abstract][Full Text] [Related]
3. Regulation of isoprenoid/cholesterol biosynthesis in cells from mevalonate kinase-deficient patients.
Houten SM; Schneiders MS; Wanders RJ; Waterham HR
J Biol Chem; 2003 Feb; 278(8):5736-43. PubMed ID: 12477733
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of squalene synthase but not squalene cyclase prevents mevalonate-mediated suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase synthesis at a posttranscriptional level.
Peffley DM; Gayen AK
Arch Biochem Biophys; 1997 Jan; 337(2):251-60. PubMed ID: 9016820
[TBL] [Abstract][Full Text] [Related]
5. Temperature dependence of mutant mevalonate kinase activity as a pathogenic factor in hyper-IgD and periodic fever syndrome.
Houten SM; Frenkel J; Rijkers GT; Wanders RJ; Kuis W; Waterham HR
Hum Mol Genet; 2002 Dec; 11(25):3115-24. PubMed ID: 12444096
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the isoprenoid biosynthesis pathway; detection of intermediates by UPLC-MS/MS.
Henneman L; van Cruchten AG; Kulik W; Waterham HR
Biochim Biophys Acta; 2011 Apr; 1811(4):227-33. PubMed ID: 21237288
[TBL] [Abstract][Full Text] [Related]
7. Compromized geranylgeranylation of RhoA and Rac1 in mevalonate kinase deficiency.
Henneman L; Schneiders MS; Turkenburg M; Waterham HR
J Inherit Metab Dis; 2010 Oct; 33(5):625-32. PubMed ID: 20814828
[TBL] [Abstract][Full Text] [Related]
8. Isoprenoid biosynthesis in hereditary periodic fever syndromes and inflammation.
Houten SM; Frenkel J; Waterham HR
Cell Mol Life Sci; 2003 Jun; 60(6):1118-34. PubMed ID: 12861380
[TBL] [Abstract][Full Text] [Related]
9. A role for geranylgeranylation in interleukin-1beta secretion.
Mandey SH; Kuijk LM; Frenkel J; Waterham HR
Arthritis Rheum; 2006 Nov; 54(11):3690-5. PubMed ID: 17075828
[TBL] [Abstract][Full Text] [Related]
10. Effects of farnesyl pyrophosphate accumulation on calvarial osteoblast differentiation.
Weivoda MM; Hohl RJ
Endocrinology; 2011 Aug; 152(8):3113-22. PubMed ID: 21586555
[TBL] [Abstract][Full Text] [Related]
11. [MVK gene abnormality and new approach to treatment of hyper IgD syndrome and periodic fever syndrome].
Naruto T
Nihon Rinsho Meneki Gakkai Kaishi; 2007 Apr; 30(2):86-9. PubMed ID: 17473510
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of squalene synthase and squalene epoxidase in tobacco cells triggers an up-regulation of 3-hydroxy-3-methylglutaryl coenzyme a reductase.
Wentzinger LF; Bach TJ; Hartmann MA
Plant Physiol; 2002 Sep; 130(1):334-46. PubMed ID: 12226513
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cholesterol production but not of nonsterol isoprenoid products induces neuronal cell death.
Michikawa M; Yanagisawa K
J Neurochem; 1999 Jun; 72(6):2278-85. PubMed ID: 10349836
[TBL] [Abstract][Full Text] [Related]
14. Squalene synthase, a determinant of Raft-associated cholesterol and modulator of cancer cell proliferation.
Brusselmans K; Timmermans L; Van de Sande T; Van Veldhoven PP; Guan G; Shechter I; Claessens F; Verhoeven G; Swinnen JV
J Biol Chem; 2007 Jun; 282(26):18777-85. PubMed ID: 17483544
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and genetic aspects of mevalonate kinase and its deficiency.
Houten SM; Wanders RJ; Waterham HR
Biochim Biophys Acta; 2000 Dec; 1529(1-3):19-32. PubMed ID: 11111075
[TBL] [Abstract][Full Text] [Related]
16. Differential Regulation of Gene Expression by Cholesterol Biosynthesis Inhibitors That Reduce (Pravastatin) or Enhance (Squalestatin 1) Nonsterol Isoprenoid Levels in Primary Cultured Mouse and Rat Hepatocytes.
Rondini EA; Duniec-Dmuchowski Z; Cukovic D; Dombkowski AA; Kocarek TA
J Pharmacol Exp Ther; 2016 Aug; 358(2):216-29. PubMed ID: 27225895
[TBL] [Abstract][Full Text] [Related]
17. Mutational spectrum and genotype-phenotype correlations in mevalonate kinase deficiency.
Mandey SH; Schneiders MS; Koster J; Waterham HR
Hum Mutat; 2006 Aug; 27(8):796-802. PubMed ID: 16835861
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of the MVK and TNFRSF1A genes in patients with a clinical presentation typical of the hyperimmunoglobulinemia D with periodic fever syndrome: a low-penetrance TNFRSF1A variant in a heterozygous MVK carrier possibly influences the phenotype of hyperimmunoglobulinemia D with periodic fever syndrome or vice versa.
Stojanov S; Lohse P; Lohse P; Hoffmann F; Renner ED; Zellerer S; Kéry A; Shin YS; Haas D; Hoffmann GF; Belohradsky BH
Arthritis Rheum; 2004 Jun; 50(6):1951-8. PubMed ID: 15188372
[TBL] [Abstract][Full Text] [Related]
19. Carrier frequency of the V377I (1129G>A) MVK mutation, associated with Hyper-IgD and periodic fever syndrome, in the Netherlands.
Houten SM; van Woerden CS; Wijburg FA; Wanders RJ; Waterham HR
Eur J Hum Genet; 2003 Feb; 11(2):196-200. PubMed ID: 12634869
[TBL] [Abstract][Full Text] [Related]
20. Quantification of mevalonate-5-phosphate using UPLC-MS/MS for determination of mevalonate kinase activity.
Reitzle L; Maier B; Stojanov S; Teupser D; Muntau AC; Vogeser M; Gersting SW
Clin Biochem; 2015 Aug; 48(12):781-7. PubMed ID: 25982894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
